Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
2 Nov 2017	Submitted	Original manuscript
14 May 2018	Reviewed	Reviewer Report - Dan Denis
4 Aug 2018	Author responded	Author comments - Jeff Zarp Petersen
Resubmission - Version 2
4 Aug 2018	Submitted	Manuscript version 2
14 Aug 2018	Reviewed	Reviewer Report - Dan Denis
20 Aug 2018	Author responded	Author comments - Jeff Zarp Petersen
Resubmission - Version 3
20 Aug 2018	Submitted	Manuscript version 3
15 Oct 2018	Reviewed	Reviewer Report - Angela Hassiotis
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
16 Oct 2018	Editorially accepted
6 Nov 2018	Article published	10.1186/s13063-018-2995-7

Back to article page